<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Infections due to Streptococcus bovis/Streptococcus equinus complex (SBSEC; formerly group D streptococci)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Infections due to Streptococcus bovis/Streptococcus equinus complex (SBSEC; formerly group D streptococci)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Infections due to Streptococcus bovis/Streptococcus equinus complex (SBSEC; formerly group D streptococci)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bruno Hoen, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 29, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The <em>Streptococcus bovis</em>/<em>Streptococcus equinus </em>complex (SBSEC; formerly group D streptococci) includes four major species  (<a class="graphic graphic_table graphicRef89670" href="/z/d/graphic/89670.html" rel="external">table 1</a>) [<a href="#rid1">1</a>]. </p><p>SBSEC members are gram-positive cocci that are an important cause of bacteremia and infective endocarditis (IE) in adults. In addition, there is a strong association between infection due to SBSEC members and colonic neoplasm (as well as other lesions of the gastrointestinal tract). </p><p>Issues related to the microbiology, epidemiology, clinical manifestations, diagnostic evaluation, and management of bacteremia and other forms of infection due to SBSEC will be discussed here. Issues related to management of IE are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/118215.html" rel="external">"Overview of management of infective endocarditis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis"</a> and  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis"</a>.)</p><p class="headingAnchor" id="H1600455228"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H4020096667"><span class="h2">Taxonomy</span><span class="headingEndMark"> — </span>The taxonomy of SBSEC was established in 2003 and is summarized in the table  (<a class="graphic graphic_table graphicRef89670" href="/z/d/graphic/89670.html" rel="external">table 1</a>). Some laboratories report these organisms under the common name <em>S. bovis</em> or <em>S. bovis</em> group [<a href="#rid2">2,3</a>]. </p><p>In one study including more than 50 blood isolates of SBSEC identified to the subspecies level by 16S rRNA sequencing, detected species included <em>Streptococcus gallolyticus</em> subsp <em>gallolyticus</em>, <em>Streptococcus infantarius</em> subsp<em> coli</em>,<em> </em>and <em>Streptococcus gallolyticu</em>s subsp<em> pasteurianu</em>s (50, 29, and 21 percent, respectively) [<a href="#rid4">4</a>]. Similarly, in another study including more than 50 blood isolates of SBSEC, the two most frequent strains were <em>S. gallolyticus</em> subsp <em>gallolyticus</em> and <em>S. gallolyticus</em> subsp <em>pasteurianus</em> (36 and 23 percent, respectively) [<a href="#rid5">5</a>]. </p><p class="headingAnchor" id="H2111925911"><span class="h2">Identification</span><span class="headingEndMark"> — </span>SBSEC are catalase-negative, gram-positive cocci in pairs or chains that usually express the Lancefield group D antigen. Colonies are typically small and nonhemolytic on blood agar. Most SBSEC members grow in 40 percent bile and hydrolyze esculin [<a href="#rid4">4,6-8</a>]. </p><p>SBSEC can be distinguished from enterococci because they are pyrrolidonyl arylamidase negative, fail to hydrolyze arginine, and are typically unable to grow in 6.5 percent salt broth [<a href="#rid4">4,6,9</a>]. However, the traditional tests for enterococci (salt tolerance, growth on bile esculin agar, and expression of Lancefield group D antigen) may not allow a definitive distinction between enterococci and SBSEC, so additional biochemical testing or molecular techniques are needed to avoid misidentification [<a href="#rid4">4,10</a>].</p><p>Most clinical microbiology laboratories in the United States use automated testing equipment or other methods for identification to the species and subspecies level. Compared with gene sequencing, matrix-assisted laser desorption/ionization-time of flight appears to be as effective, quicker, and less expensive for SBSEC subspecies identification [<a href="#rid2">2,11,12</a>]. </p><p>Occasionally, viridans group streptococci (especially <em>Streptococcus salivarius</em>) are misidentified as SBSEC. SBSEC may be differentiated from viridans group streptococci and identified to the species/subspecies level using commercially available kits and automating testing equipment found in most United States clinical microbiology laboratories [<a href="#rid4">4,9,13,14</a>]. </p><p class="headingAnchor" id="H283710063"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H2659259208"><span class="h2">Bloodstream infection</span><span class="headingEndMark"> — </span>Among hospitalized patients, SBSEC accounts for approximately 5 percent of streptococcal bloodstream isolates [<a href="#rid15">15</a>]. Among patients with infective endocarditis (IE), SBSEC accounts for 2 to 57 percent of organisms in various series [<a href="#rid16">16-20</a>]. <em>S. bovis</em> biotype I is a more frequent cause of IE than <em>S. bovis</em> biotype II. Among patients with bacteremia due to <em>S. bovis</em> biotype I (<em>S. gallolyticus</em> subsp <em>gallolyticus</em>), IE has been observed in 43 to 100 percent of cases; among patients with bacteremia due to <em>S. bovis</em> biotype II (<em>S. gallolyticus</em> subs <em>pasteurianus</em> and <em>S. infantarius</em>), IE has been observed in 8 to 29 percent of cases [<a href="#rid16">16,21</a>]. In a cohort study including 210 episodes of SBSEC bacteremia, the proportions of IE among SBSEC subspecies for <em>S. gallolyticus</em>, <em>S. infantarius</em>, <em>S. pasteurianus</em>, and <em>S. lutetiensis</em> were 33, 16, 5, and 5 percent, respectively [<a href="#rid22">22</a>].</p><p>SBSEC have emerged as important etiologic agents of IE in some geographic areas [<a href="#rid16">16-18,23,24</a>]. In one study based on data from the International Collaboration on Endocarditis, SBSEC accounted for 57 percent of IE in France, 9 percent in the rest of Europe, and 6 percent in the United States [<a href="#rid18">18</a>]. Similarly, in an analysis of a large database of IE isolates between 2000 and 2005, the proportion of IE caused by SBSEC in Europe was 10 percent, fivefold higher than in the United States [<a href="#rid16">16</a>]. The reason for these geographic disparities is uncertain; higher rates of IE in certain regions do not appear to be associated with differences in fecal carriage rates [<a href="#rid25">25</a>]. It has been speculated that diet may play a role [<a href="#rid26">26-28</a>]. </p><p>Many series report a higher incidence of IE due to SBSEC in men [<a href="#rid16">16,29-31</a>]. In addition, patients with IE due to SBSEC are typically older than patients with IE due to other organisms (mean age 59 to 67 years versus 46 to 59 years) [<a href="#rid16">16,18,19,24</a>]. Patients with IE due to SBSEC are less likely to have risk factors that predispose to development of IE (such as intravenous drug use or structural heart disease) [<a href="#rid16">16,18,23,24</a>]. Conversely, such patients are more likely to have chronic conditions such as diabetes and chronic liver disease, especially cirrhosis [<a href="#rid24">24,26</a>].</p><p>SBSEC bloodstream infection has been associated with hepatic disease; in such cases, dysfunction of the reticuloendothelial system may compromise bacterial clearance, allowing entry of organisms into the portal or systemic circulation [<a href="#rid4">4,24,30</a>]. Bacteremia of hepatobiliary origin is more frequently associated with S bovis biotype II than <em>S. bovis</em> biotype I; in addition, polymicrobial infection may be observed [<a href="#rid16">16,32,33</a>]. </p><p>In one study including more than 190 patients with IE (including 30 patients with IE due to <em>S. bovis</em>), advanced liver disease was observed more frequently among patients with IE due to <em>S. bovis</em> biotype I than among patients with non-SBSEC endocarditis (56 versus 15 percent) [<a href="#rid24">24</a>]. In another study including 64 patients with <em>S. bovis</em> bacteremia, infection due to <em>S. bovis</em> biotype II was more frequently associated with a hepatobiliary origin than infection due to <em>S. bovis</em> biotype I (50 versus 5 percent, respectively) [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H1946035951"><span class="h2">Association with colonic neoplasia</span><span class="headingEndMark"> — </span>The association between SBSEC bacteremia, IE, and colonic neoplasia is well described [<a href="#rid21">21,30,34,35</a>]. In a multivariate analysis including more than 220 patients with <em>S. bovis</em> bacteremia (159 due to <em>S. bovis</em> biotype I and 64 due to <em>S. bovis</em> biotype II), <em>S. bovis</em> biotype I bacteremia was independently associated with colonic neoplasia (odds ratio [OR] 5.7, 95 % CI 3.0-10.9) [<a href="#rid36">36</a>]. In a meta-analysis including 11 studies of patients with <em>S. bovis</em> infection who underwent colonic evaluation, the median percentage who had concomitant colonic neoplasia was 60 percent (interquartile range, 22 percent), which exceeded the rate of colonic neoplasia in the general asymptomatic population [<a href="#rid21">21</a>]. In addition, colonic neoplasia occurred more frequently among patients with <em>S. bovis</em> IE than among patients with other forms of <em>S. bovis</em> infection (pooled OR 3.72, 95% CI 2.03-6.81). </p><p>Bloodstream infection due <em>S. bovis</em> biotype I (<em>S. gallolyticus</em> subsp <em>gallolyticus</em>) has been more strongly associated with colonic neoplasia than bloodstream infection due to <em>S. bovis</em> biotype II [<a href="#rid1">1,21,32,35</a>]. In the above meta-analysis, patients with <em>S. bovis</em> biotype I infection had increased risk of colonic neoplasia (pooled OR 7.26, 95% CI 3.94-13.36) and IE (pooled OR 16.61, 95% CI 8.85-31.16) relative to patients with <em>S. bovis</em> biotype II infection [<a href="#rid21">21</a>]. In the above multivariate analysis, there was no association between <em>S. bovis</em> biotype II bacteremia and colonic neoplasia (OR 0.17, 95% CI 0.09-0.33) [<a href="#rid36">36</a>]. </p><p>The reason for the association between <em>S. bovis</em> biotype I bloodstream infection and colonic neoplasia is not fully understood; it may be related to presence of proteins in <em>S. bovis</em> biotype I that bind to overexpressed ligands in colonic neoplasms [<a href="#rid37">37</a>]. Selective colonization of colorectal cancer tissue has been suggested for <em>S. gallolyticus</em> subsp <em>gallolyticus</em>, possibly related to increased adhesion to cancerous cell types with enhanced collagen type IV accessibility. <em>S. gallolyticus</em> subsp <em>gallolyticus</em> can colonize, proliferate, and may shape the tumor microenvironment to their benefit [<a href="#rid1">1</a>]. In addition, <em>S. gallolyticus </em>subsp<em> gallolyticus</em> appears uniquely capable of forming biofilms on collagen-rich surfaces such as valve endothelium [<a href="#rid37">37</a>]. </p><p>The strength of the relationship between SBSEC stool carriage and colonic neoplasia is uncertain, and it is unclear whether SBSEC plays a role in the oncogenic progression of normal colonic mucosa to neoplasia [<a href="#rid34">34,38-42</a>]. SBSEC stool carriage appears to be more commonly associated with <em>S. bovis </em>biotype II than <em>S. bovis</em> biotype I [<a href="#rid25">25,43</a>]. As an example, in one French study including more than 250 patients undergoing colonoscopy, the SBSEC stool carriage rate was 4.6 percent; among the stool isolates, <em>S. bovis</em> biotype II was observed more frequently than <em>S. bovis</em> biotype I (92 versus 8 percent) [<a href="#rid25">25</a>]. The SBSEC fecal carriage rate was 11 percent among patients with colonic neoplasia. </p><p>Correlation between SBSEC infection and other lesions of the gastrointestinal tract has also been described, including gastric carcinoma, premalignant or benign polyps, lymphoma, colitis, and mechanical abnormalities [<a href="#rid29">29,30,44-48</a>].</p><p class="headingAnchor" id="H2"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Clinical manifestations of SBSEC infection include bacteremia (with or without infective endocarditis [IE]) and SBSEC infection in the absence of bacteremia or IE. The gastrointestinal tract is the most important portal of entry; other potential sources of infection include the urinary tract and hepatobiliary tree. </p><p class="headingAnchor" id="H1612075351"><span class="h2">Bacteremia and endocarditis</span><span class="headingEndMark"> — </span>Clinical history and physical manifestations of IE due to SBSEC are comparable with manifestations of IE caused by other organisms [<a href="#rid18">18,31</a>]. The presentation is usually subacute (with fever lasting days or weeks), but occasionally acute onset occurs [<a href="#rid6">6</a>]. Nonspecific symptoms may include fever, anorexia, weight loss, fatigue, night sweats, and weakness. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Symptoms and signs'</a>.)</p><p>In general, IE may be associated with an array of complications due to septic embolization. Clinical manifestations reflecting these complications may be present at the time of initial presentation and/or may develop subsequently. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Complications as initial presentation'</a>.)</p><p>Patients with SBSEC IE tend to have relatively large vegetations. In one study including more than 200 patients with definite IE by Duke criteria, vegetation size &gt;10 mm was observed more frequently in the setting of SBSEC IE than in the setting of IE caused by other streptococci and nonstreptococcal pathogens (50 percent versus 20 and 34 percent, respectively) [<a href="#rid49">49</a>].</p><p>IE due to SBSEC may be highly destructive, resulting in valve perforation or invasive disease with cardiac septal or valvular ring abscess [<a href="#rid18">18,29</a>]. In one case series including more than 170 patients with IE, infiltration of the left ventricle was observed more frequently in the setting of IE due to SBSEC than other causes of IE (36 versus 10 percent) [<a href="#rid50">50</a>]. Compared with patients with IE due to other organisms, patients with SBSEC were older, had a longer interval prior to diagnosis, and required surgery more often. Bivalvular involvement has been observed more frequently among patients with IE due to <em>S. bovis</em> than to viridans group streptococci [<a href="#rid16">16</a>].</p><p>Data are conflicting as to whether embolic events are more common in IE caused by SBSEC compared with other pathogens [<a href="#rid23">23,24,26,50</a>]. </p><p>Patients with SBSEC infection may present with complications of bacteremia or IE (such as neurologic complications, septic emboli, or metastatic infection). (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Complications as initial presentation'</a>.)</p><p class="headingAnchor" id="H3998895316"><span class="h2">Other forms of infection</span><span class="headingEndMark"> — </span>SBSEC infection may present in the absence of bacteremia or IE. Forms of infection include: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bone and joint infection</strong> – Forms of bone and joint infection attributed to SBSEC include septic arthritis, prosthetic joint infection, spondylitis, discitis, and osteomyelitis [<a href="#rid16">16,24,51-53</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Meningitis</strong> – SBSEC meningitis has been described in infants [<a href="#rid54">54-56</a>] and adults; in adults, meningitis has been observed in association with SBSEC bacteremia and endocarditis [<a href="#rid57">57-60</a>]. In one study including more than 4800 cases of bacterial meningitis in patients &lt;18 years, SBSEC was the cause in 0.5 percent of cases [<a href="#rid56">56</a>]. For cases in which SBSEC was identified, <em>S. gallolyticus</em> subsp<em> pasteurianus</em> comprised 80 percent of cases. In addition, there are case reports describing GDS bacteremia and meningitis complicating <em>Strongyloides stercoralis</em> infection [<a href="#rid61">61,62</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonatal sepsis</strong> – The organism <em>S. gallolyticus</em> subsp <em>pasteurianus</em> has been associated with neonatal sepsis, with or without meningitis; clinically, such infections may be indistinguishable from infection caused by <em>Streptococcus agalactiae</em> [<a href="#rid54">54,63,64</a>]. Clusters of <em>S. pasteurianus</em> infections may develop in neonatal intensive care units as a result of nosocomial transmission [<a href="#rid63">63-65</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intrapartum bacteremia</strong> – Intrapartum infections caused by <em>S. gallolyticus </em>subsp <em>gallolyticus</em> complicated with chorioamnionitis and bacteremia have been described; in most cases, sepsis developed among neonates born to infected mothers [<a href="#rid66">66</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peritonitis</strong> – Spontaneous peritonitis due to SBSEC has been described [<a href="#rid67">67-69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary tract infection</strong> – Urinary tract infection due to SBSEC has been described [<a href="#rid70">70,71</a>].</p><p></p><p class="headingAnchor" id="H8"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>In general, infection due to SBSEC usually comes to clinical attention via culture of the organism from blood, other body fluid, or tissue. (See <a class="local">'Microbiology'</a> above.)</p><p class="headingAnchor" id="H3097119212"><span class="h2">Patients with bacteremia</span><span class="headingEndMark"> — </span>Patients with SBSEC bacteremia warrant routine laboratory testing (chemistries, assessment of renal function, complete blood count) as well as liver function testing. In addition, such patients warrant careful evaluation for IE and colonic neoplasia:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for infective endocarditis (IE)</strong> – In general, patients with SBSEC bacteremia should undergo echocardiography, beginning with a transthoracic echocardiogram (TTE). Transesophageal echocardiography (TEE) is warranted in the following circumstances:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Negative or technically inadequate TTE with high clinical suspicion for IE (persistent bacteremia despite appropriate antimicrobial therapy and/or multiple minor criteria for endocarditis).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Positive TTE with concern for presence of intracardiac complications such as paravalvular abscess (risk factors include new conduction delay on electrocardiogram, aortic valve endocarditis, and persistent bacteremia or fever despite appropriate antimicrobial therapy), or significant valvular regurgitation (to determine need for surgery).</p><p></p><p class="bulletIndent1">In general, for patients with prompt clearance of bacteremia on antibiotic therapy, in the absence of IE stigmata, significant valvular regurgitation, aortic stenosis, prosthetic valve or other intracardiac device, TTE is sufficient if normal. </p><p></p><p class="bulletIndent1">Issues related to diagnosis of IE are discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">"Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Clinical manifestations'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluate for complications of IE</strong> – Radiographic imaging to evaluate for complications of IE should be tailored to findings on history and physical examination. As examples, abdominal imaging with computed tomography is appropriate for patients with localized pain, signs of peritonitis, or persistent fever and/or leukocytosis. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for neoplasia</strong> – We are in agreement with the American Heart Association/Infectious Diseases Society of America guidelines, which recommend that adults with SBSEC bacteremia undergo colonoscopy to evaluate for carcinoma or other colonic lesions [<a href="#rid72">72</a>]. Colonoscopy is most important for patients with bacteremia due to <em>S. bovis</em> biotype I (<em>S. gallolyticus</em> subsp <em>gallolyticus</em>) and <em>S. bovis</em> isolates not identified to the subspecies level. If negative, colonoscopy should be repeated in four to six months. This approach is based upon on the strong epidemiologic association between SBSEC and colon cancer, rather than on outcome data. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation for underlying liver disease</strong> – Patients with SBSEC bacteremia should have liver function tests (LFTs) sent, and individuals with risk factors for hepatitis B or C infection should be tested for these conditions. Patients with abnormal LFTs, spontaneous peritonitis, and/or signs of cirrhosis on physical examination  (<a class="graphic graphic_table graphicRef90943" href="/z/d/graphic/90943.html" rel="external">table 2</a>) should undergo abdominal ultrasound. (See  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H99459693"><span class="h2">Patients with other forms of infection</span><span class="headingEndMark"> — </span>Evaluation of patients presenting with other forms SBSEC infection (apart from or in addition to bacteremia) should consist of investigation guided by the clinical presentation, tailored to individual circumstances (see related topics). As an example, patients with focal joint pain and effusion should undergo diagnostic joint aspiration to evaluate for septic arthritis. </p><p>In addition, such patients should have surveillance blood cultures (if not already collected) and TTE, as described above for patients with bacteremia, since metastatic infection may reflect bloodstream infection and/or IE. (See <a class="local">'Patients with bacteremia'</a> above.) </p><p class="headingAnchor" id="H1612075375"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H269738667"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Patients with SBSEC infection should undergo clinical evaluation as described above. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p>Management of SBSEC should be guided by the clinical presentation, tailored to individual circumstances (see related topics). As an example, patients with septic arthritis should undergo joint drainage.</p><p>Issues related to antibiotic selection are discussed below. </p><p class="headingAnchor" id="H3519408397"><span class="h2">Antibiotic selection</span><span class="headingEndMark"> — </span>In general, similar antibiotic susceptibility profiles have been observed among the various species and subspecies of the SBSEC group; typically SBSEC are susceptible to penicillins, <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a>, carbapenems, <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">vancomycin</a>, <a class="drug drug_general" data-topicid="9304" href="/z/d/drug information/9304.html" rel="external">daptomycin</a>, and <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">linezolid</a> [<a href="#rid4">4,73,74</a>].</p><p>Antibiotic agents that may not be reliably active against SBSEC include fluoroquinolones, <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, tetracyclines, macrolides, and <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> [<a href="#rid24">24,75-77</a>]. In a 2019 review, which included all papers published since 2000 with reported resistance rates among SBSEC isolates, <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a>, <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a>, and clindamycin were the antimicrobial agents showing the highest resistance rates (36 to 77 percent for tetracycline, 9 to 78 percent for erythromycin, and 11 to 62 percent for clindamycin). Most isolates were susceptible to penicillin; no isolates were resistant to <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a>, glycopeptides, <a class="drug drug_general" data-topicid="9304" href="/z/d/drug information/9304.html" rel="external">daptomycin</a>, or <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">linezolid</a> [<a href="#rid77">77</a>]. </p><p class="headingAnchor" id="H1612075398"><span class="h3">Bacteremia</span><span class="headingEndMark"> — </span>For treatment of SBSEC bacteremia, we favor <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a> (2 g intravenously every 24 hours); penicillin (12 to 24 million units intravenously daily, divided every four hours) may be used, but logistics of administration are less convenient. <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">Vancomycin</a>  (<a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">table 3</a>) is an acceptable alternative agent for patients with hypersensitivity to beta-lactam agents. Subsequent management should be guided by antibiotic susceptibility data. </p><p>Surveillance blood cultures should be obtained to document clearance of bacteremia. Persist bacteremia despite appropriate antibiotic therapy should prompt further investigation for the source of persistent infection (eg, cardiac, intravascular, device-related, or abscess). </p><p>The duration of therapy for treatment of bacteremia (in the absence of other clinical manifestations) is two weeks. It is uncertain whether intravenous therapy is required for the entire duration of antibiotic therapy. Following clearance of bacteremia and resolution of systemic signs of infection, it may be reasonable to complete the course of antibiotic therapy with an oral regimen (such as <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">amoxicillin</a> 500 mg three times daily or 875 mg [extended release] twice daily). Alternative agents for patients with hypersensitivity to beta-lactam agents include <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">cephalexin</a> (500 mg orally four times daily) or <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">clindamycin</a> (300 to 450 mg orally three times daily).</p><p>For patients with endocarditis or other manifestations of SBSEC infection (apart from or in addition to bacteremia), the duration of therapy depends on the nature of the underlying infection. (See <a class="local">'Endocarditis'</a> below and <a class="local">'Other manifestations'</a> below.)</p><p class="headingAnchor" id="H2169748199"><span class="h3">Endocarditis</span><span class="headingEndMark"> — </span>Issues related to treatment of endocarditis are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Viridans streptococci and S. bovis/S. equinus complex'</a> and  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis", section on 'Streptococci'</a>.)</p><p class="headingAnchor" id="H2509475484"><span class="h3">Other manifestations</span><span class="headingEndMark"> — </span>For patients with other manifestations of SBSEC infection, the choice and duration of therapy depends on the nature of the underlying infection, as discussed in the following sections:</p><p class="bulletIndent1"><span class="glyph">●</span>Osteomyelitis (see  <a class="medical medical_review" href="/z/d/html/114350.html" rel="external">"Nonvertebral osteomyelitis in adults: Treatment"</a> and  <a class="medical medical_review" href="/z/d/html/7663.html" rel="external">"Vertebral osteomyelitis and discitis in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Prosthetic joint infection (see  <a class="medical medical_review" href="/z/d/html/7665.html" rel="external">"Prosthetic joint infection: Treatment"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Septic arthritis (see  <a class="medical medical_review" href="/z/d/html/7666.html" rel="external">"Septic arthritis in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Meningitis (see  <a class="medical medical_review" href="/z/d/html/1283.html" rel="external">"Treatment of bacterial meningitis caused by specific pathogens in adults"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Neonatal sepsis (see  <a class="medical medical_review" href="/z/d/html/5046.html" rel="external">"Management and outcome of sepsis in term and late preterm neonates"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Peritonitis (see  <a class="medical medical_review" href="/z/d/html/1248.html" rel="external">"Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis"</a>)</p><p></p><p class="headingAnchor" id="H1612075409"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>The <em>Streptococcus bovis</em>/<em>Streptococcus equinus </em>complex (SBSEC) includes four major species; the taxonomy is summarized in the table  (<a class="graphic graphic_table graphicRef89670" href="/z/d/graphic/89670.html" rel="external">table 1</a>). SBSEC are gram-positive cocci that are an important cause of bacteremia and infective endocarditis (IE) in adults. In addition, there is a strong association between SBSEC infection and colonic neoplasm (as well as other lesions of the gastrointestinal tract), especially for <em>S. gallolyticus</em>. (See <a class="local">'Introduction'</a> above and <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among hospitalized patients, SBSEC accounts for approximately 5 percent of streptococcal bloodstream isolates. Patients with IE due to SBSEC are typically older than patients with IE due to other organisms, are less likely to have risk factors that predispose to development of IE (such as intravenous drug use or structural heart disease), and are more likely to have chronic conditions such as diabetes and chronic liver disease. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical presentations of SBSEC infection include bacteremia (with or without IE, with or without complications such as septic emboli or metastatic infection) and other forms of SBSEC infection (in the absence of bacteremia or IE). Clinical history and physical manifestations of IE due to SBSEC are comparable with manifestations of IE caused by other organisms. The gastrointestinal tract is the most important portal of entry; other potential sources of infection include the urinary tract and hepatobiliary tree. (See <a class="local">'Clinical manifestations'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In general, infection due to SBSEC usually comes to clinical attention via culture of the organism from blood, other body fluid, or tissue. Patients with SBSEC bacteremia warrant liver function tests and careful evaluation for IE. In addition, colonoscopy is warranted to evaluate for carcinoma or other colonic lesions; this approach is based upon on the strong epidemiologic association between SBSEC and colon cancer, rather than on outcome data. Patients presenting with other forms of SBSEC infection (apart from or in addition to bacteremia) warrant evaluation guided by the clinical presentation, tailored to individual circumstances. (See <a class="local">'Diagnostic evaluation'</a> above and <a class="local">'Association with colonic neoplasia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For treatment of SBSEC bacteremia, we favor <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">ceftriaxone</a>; penicillin may be used, but logistics of administration are less convenient. <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">Vancomycin</a> is an acceptable alternative agent for patients with hypersensitivity to beta-lactam agents. Subsequent management should be guided by antibiotic susceptibility data. (See <a class="local">'Bacteremia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Issues related to treatment of endocarditis are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">"Antimicrobial therapy of left-sided native valve endocarditis", section on 'Viridans streptococci and S. bovis/S. equinus complex'</a> and  <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">"Antimicrobial therapy of prosthetic valve endocarditis", section on 'Streptococci'</a>.)</p><p></p><p class="headingAnchor" id="H5373757"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. Howard Gold, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Jans C, Boleij A. The Road to Infection: Host-Microbe Interactions Defining the Pathogenicity of Streptococcus bovis/Streptococcus equinus Complex Members. Front Microbiol 2018; 9:603.</a></li><li><a class="nounderline abstract_t">Dekker JP, Lau AF. An Update on the Streptococcus bovis Group: Classification, Identification, and Disease Associations. J Clin Microbiol 2016; 54:1694.</a></li><li><a class="nounderline abstract_t">van't Wout JW, Bijlmer HA. Bacteremia due to Streptococcus gallolyticus, or the perils of revised nomenclature in bacteriology. Clin Infect Dis 2005; 40:1070.</a></li><li><a class="nounderline abstract_t">Beck M, Frodl R, Funke G. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol 2008; 46:2966.</a></li><li><a class="nounderline abstract_t">Marmolin ES, Hartmeyer GN, Christensen JJ, et al. Bacteremia with the bovis group streptococci: species identification and association with infective endocarditis and with gastrointestinal disease. Diagn Microbiol Infect Dis 2016; 85:239.</a></li><li><a class="nounderline abstract_t">Moellering RC Jr, Watson BK, Kunz LJ. Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci. Am J Med 1974; 57:239.</a></li><li class="breakAll">Roberts RB. Streptococcal endocarditis: The viridans and beta hemolytic streptococci. In: Infective Endocarditis, Kaye D (Ed), Raven Press, Ltd, New York 1992. p.91.</li><li><a class="nounderline abstract_t">Chuard C, Reller LB. Bile-esculin test for presumptive identification of enterococci and streptococci: effects of bile concentration, inoculation technique, and incubation time. J Clin Microbiol 1998; 36:1135.</a></li><li><a class="nounderline abstract_t">Ruoff KL, Miller SI, Garner CV, et al. Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 1989; 27:305.</a></li><li><a class="nounderline abstract_t">Ellmerich S, Schöller M, Duranton B, et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 2000; 21:753.</a></li><li><a class="nounderline abstract_t">Ben-Chetrit E, Wiener-Well Y, Kashat L, et al. Streptococcus bovis new taxonomy: does subspecies distinction matter? Eur J Clin Microbiol Infect Dis 2017; 36:387.</a></li><li><a class="nounderline abstract_t">Gherardi G, Palmieri C, Marini E, et al. Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus. Diagn Microbiol Infect Dis 2016; 86:329.</a></li><li><a class="nounderline abstract_t">Clarridge JE 3rd, Attorri SM, Zhang Q, Bartell J. 16S ribosomal DNA sequence analysis distinguishes biotypes of Streptococcus bovis: Streptococcus bovis Biotype II/2 is a separate genospecies and the predominant clinical isolate in adult males. J Clin Microbiol 2001; 39:1549.</a></li><li><a class="nounderline abstract_t">Haanperä M, Jalava J, Huovinen P, et al. Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. J Clin Microbiol 2007; 45:762.</a></li><li><a class="nounderline abstract_t">Marín M, Gudiol C, Garcia-Vidal C, et al. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore) 2014; 93:143.</a></li><li><a class="nounderline abstract_t">Corredoira J, Alonso MP, Coira A, et al. Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur J Clin Microbiol Infect Dis 2008; 27:285.</a></li><li><a class="nounderline abstract_t">Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463.</a></li><li><a class="nounderline abstract_t">Hoen B, Chirouze C, Cabell CH, et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis 2005; 24:12.</a></li><li><a class="nounderline abstract_t">Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008; 168:2095.</a></li><li><a class="nounderline abstract_t">Olmos C, Vilacosta I, Sarriá C, et al. Streptococcus bovis endocarditis: Update from a multicenter registry. Am Heart J 2016; 171:7.</a></li><li><a class="nounderline abstract_t">Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 2011; 53:870.</a></li><li><a class="nounderline abstract_t">Öberg J, Nilson B, Gilje P, et al. Bacteraemia and infective endocarditis with Streptococcus bovis-Streptococcus equinus-complex: a retrospective cohort study. Infect Dis (Lond) 2022; 54:760.</a></li><li><a class="nounderline abstract_t">Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288:75.</a></li><li><a class="nounderline abstract_t">Tripodi MF, Adinolfi LE, Ragone E, et al. Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor. Clin Infect Dis 2004; 38:1394.</a></li><li><a class="nounderline abstract_t">Chirouze C, Patry I, Duval X, et al. Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection. Eur J Clin Microbiol Infect Dis 2013; 32:1171.</a></li><li><a class="nounderline abstract_t">Giannitsioti E, Chirouze C, Bouvet A, et al. Characteristics and regional variations of group D streptococcal endocarditis in France. Clin Microbiol Infect 2007; 13:770.</a></li><li><a class="nounderline abstract_t">Dumke J, Hinse D, Vollmer T, et al. Potential Transmission Pathways of Streptococcus gallolyticus subsp. gallolyticus. PLoS One 2015; 10:e0126507.</a></li><li><a class="nounderline abstract_t">Romero-Hernández B, Tedim AP, Sánchez-Herrero JF, et al. Streptococcus gallolyticus subsp. gallolyticus from human and animal origins: genetic diversity, antimicrobial susceptibility, and characterization of a vancomycin-resistant calf isolate carrying a vanA-Tn1546-like element. Antimicrob Agents Chemother 2015; 59:2006.</a></li><li><a class="nounderline abstract_t">Ballet M, Gevigney G, Garé JP, et al. Infective endocarditis due to Streptococcus bovis. A report of 53 cases. Eur Heart J 1995; 16:1975.</a></li><li><a class="nounderline abstract_t">Zarkin BA, Lillemoe KD, Cameron JL, et al. The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease. Ann Surg 1990; 211:786.</a></li><li><a class="nounderline abstract_t">Duval X, Papastamopoulos V, Longuet P, et al. Definite streptococcus bovis endocarditis: characteristics in 20 patients. Clin Microbiol Infect 2001; 7:3.</a></li><li><a class="nounderline abstract_t">Corredoira JC, Alonso MP, García JF, et al. Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis 2005; 24:250.</a></li><li><a class="nounderline abstract_t">Fernández-Ruiz M, Villar-Silva J, Llenas-García J, et al. Streptococcus bovis bacteraemia revisited: clinical and microbiological correlates in a contemporary series of 59 patients. J Infect 2010; 61:307.</a></li><li><a class="nounderline abstract_t">Klein RS, Recco RA, Catalano MT, et al. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 1977; 297:800.</a></li><li><a class="nounderline abstract_t">Corredoira-Sánchez J, García-Garrote F, Rabuñal R, et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis 2012; 55:491.</a></li><li><a class="nounderline abstract_t">Corredoira JC, Alonso MP, García-País MJ, et al. Is colonoscopy necessary in cases of infection by Streptococcus bovis biotype II? Eur J Clin Microbiol Infect Dis 2014; 33:171.</a></li><li><a class="nounderline abstract_t">Boleij A, Muytjens CM, Bukhari SI, et al. Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis 2011; 203:1101.</a></li><li><a class="nounderline abstract_t">Klein RS, Catalano MT, Edberg SC, et al. Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med 1979; 91:560.</a></li><li><a class="nounderline abstract_t">Potter MA, Cunliffe NA, Smith M, et al. A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol 1998; 51:473.</a></li><li><a class="nounderline abstract_t">Dubrow R, Edberg S, Wikfors E, et al. Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology 1991; 101:721.</a></li><li><a class="nounderline abstract_t">Abdulamir AS, Hafidh RR, Mahdi LK, et al. Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer 2009; 9:403.</a></li><li><a class="nounderline abstract_t">Boleij A, Tjalsma H. The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect Dis 2013; 13:719.</a></li><li><a class="nounderline abstract_t">Biarc J, Nguyen IS, Pini A, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis). Carcinogenesis 2004; 25:1477.</a></li><li><a class="nounderline abstract_t">Murray HW, Roberts RB. Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 1978; 138:1097.</a></li><li><a class="nounderline abstract_t">Burns CA, McCaughey R, Lauter CB. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol 1985; 80:42.</a></li><li><a class="nounderline abstract_t">Moshkowitz M, Arber N, Wajsman R, et al. Streptococcus bovis endocarditis as a presenting manifestation of idiopathic ulcerative colitis. Postgrad Med J 1992; 68:930.</a></li><li><a class="nounderline abstract_t">Montalto M, Izzi D, La Regina M, et al. Non-life-threatening sepsis: report of two cases. Am J Med Sci 2004; 327:275.</a></li><li><a class="nounderline abstract_t">Buqés J, Claramonte X, Martínez JA, Torres M. [Staphylococcus bovis infective endocarditis associated with gastric adenocarcinoma]. Med Clin (Barc) 1994; 103:397.</a></li><li><a class="nounderline abstract_t">Pergola V, Di Salvo G, Habib G, et al. Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol 2001; 88:871.</a></li><li><a class="nounderline abstract_t">Kupferwasser I, Darius H, Müller AM, et al. Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 1998; 80:276.</a></li><li><a class="nounderline abstract_t">García-País MJ, Rabuñal R, Armesto V, et al. Streptococcus bovis septic arthritis and osteomyelitis: A report of 21 cases and a literature review. Semin Arthritis Rheum 2016; 45:738.</a></li><li><a class="nounderline abstract_t">Emerton ME, Crook DW, Cooke PH. Streptococcus bovis-infected total hip arthroplasty. J Arthroplasty 1995; 10:554.</a></li><li><a class="nounderline abstract_t">Bajwa ZH, Ho C, Grush A, et al. Discitis associated with pregnancy and spinal anesthesia. Anesth Analg 2002; 94:415.</a></li><li><a class="nounderline abstract_t">Klatte JM, Clarridge JE 3rd, Bratcher D, Selvarangan R. A longitudinal case series description of meningitis due to Streptococcus gallolyticus subsp. pasteurianus in infants. J Clin Microbiol 2012; 50:57.</a></li><li><a class="nounderline abstract_t">Hede SV. Diagnosis and Treatment of Childhood Meningitis Caused by Streptococcus bovis Group. Curr Infect Dis Rep 2016; 18:11.</a></li><li><a class="nounderline abstract_t">Beneteau A, Levy C, Foucaud P, et al. Childhood meningitis caused by Streptococcus bovis group: clinical and biologic data during a 12-year period in France. Pediatr Infect Dis J 2015; 34:136.</a></li><li><a class="nounderline abstract_t">Gergaud JM, Breux JP, Roblot P, et al. [Neurologic complications of infectious endocarditis]. Ann Med Interne (Paris) 1995; 146:413.</a></li><li><a class="nounderline abstract_t">Cohen LF, Dunbar SA, Sirbasku DM, Clarridge JE 3rd. Streptococcus bovis infection of the central nervous system: report of two cases and review. Clin Infect Dis 1997; 25:819.</a></li><li><a class="nounderline abstract_t">van Samkar A, Brouwer MC, Pannekoek Y, et al. Streptococcus gallolyticus meningitis in adults: report of five cases and review of the literature. Clin Microbiol Infect 2015; 21:1077.</a></li><li><a class="nounderline abstract_t">Gray JD, Wilson CJ. Streptococcus gallolyticus (bovis): a rare presentation of meningitis in the ED. Am J Emerg Med 2016; 34:677.e1.</a></li><li><a class="nounderline abstract_t">Jain AK, Agarwal SK, el-Sadr W. Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 1994; 18:253.</a></li><li><a class="nounderline abstract_t">Linder JD, Mönkemüller KE, Lazenby AJ, Wilcox CM. Streptococcus bovis bacteremia associated with Strongyloides stercoralis colitis. Gastrointest Endosc 2000; 52:796.</a></li><li><a class="nounderline abstract_t">Floret N, Bailly P, Thouverez M, et al. A cluster of bloodstream infections caused by Streptococcus gallolyticus subspecies pasteurianus that involved 5 preterm neonates in a university hospital during a 2-month period. Infect Control Hosp Epidemiol 2010; 31:194.</a></li><li><a class="nounderline abstract_t">Saegeman V, Cossey V, Loens K, et al. Streptococcus Gallolyticus Subsp. Pasteurianus Infection In A Neonatal Intensive Care Unit. Pediatr Infect Dis J 2016; 35:1272.</a></li><li><a class="nounderline abstract_t">Chen WC, Lee PI, Lin HC, et al. Clustering of Streptococcus gallolyticus subspecies pasteurianus bacteremia and meningitis in neonates. J Microbiol Immunol Infect 2021; 54:1078.</a></li><li><a class="nounderline abstract_t">Sasi S, Abid FB, Wilson GJ, et al. Intrauterine infection and postpartum bacteremia due to Streptococcus gallolyticus subsp gallolyticus: An emerging concern. IDCases 2022; 29:e01562.</a></li><li><a class="nounderline abstract_t">Ackerman Z, Eliakim R, Stalnikowicz R. Spontaneous peritonitis caused by Streptococcus bovis: search for colonic neoplasia. J Clin Gastroenterol 1995; 21:263.</a></li><li><a class="nounderline abstract_t">Wong SS, Woo PC, Ho PL, Wang TK. Continuous ambulatory peritoneal dialysis-related peritonitis caused by Streptococcus bovis. Eur J Clin Microbiol Infect Dis 2003; 22:424.</a></li><li><a class="nounderline abstract_t">Eledrisi MS, Zuckerman MJ, Ho H. Spontaneous bacterial peritonitis caused by Streptococcus bovis. Am J Gastroenterol 2000; 95:1110.</a></li><li><a class="nounderline abstract_t">Matesanz M, Rubal D, Iñiguez I, et al. Is Streptococcus bovis a urinary pathogen? Eur J Clin Microbiol Infect Dis 2015; 34:719.</a></li><li><a class="nounderline abstract_t">de Teresa-Alguacil J, Gutiérrez-Soto M, Rodríguez-Granger J, et al. Clinical interest of Streptococcus bovis isolates in urine. Rev Esp Quimioter 2016; 29:155.</a></li><li><a class="nounderline abstract_t">Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132:1435.</a></li><li><a class="nounderline abstract_t">Streit JM, Steenbergen JN, Thorne GM, et al. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 2005; 55:574.</a></li><li><a class="nounderline abstract_t">Romero B, Morosini MI, Loza E, et al. Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue? J Clin Microbiol 2011; 49:3228.</a></li><li><a class="nounderline abstract_t">Leclercq R, Huet C, Picherot M, et al. Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis). Antimicrob Agents Chemother 2005; 49:1646.</a></li><li><a class="nounderline abstract_t">Rodríguez-Avial I, Rodríguez-Avial C, Culebras E, Picazo JJ. In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species. Antimicrob Agents Chemother 2005; 49:820.</a></li><li><a class="nounderline abstract_t">Pompilio A, Di Bonaventura G, Gherardi G. An Overview on Streptococcus bovis/Streptococcus equinus Complex Isolates: Identification to the Species/Subspecies Level and Antibiotic Resistance. Int J Mol Sci 2019; 20.</a></li></ol></div><div id="topicVersionRevision">Topic 3156 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29692760" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The Road to Infection: Host-Microbe Interactions Defining the Pathogenicity of Streptococcus bovis/Streptococcus equinus Complex Members.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26912760" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : An Update on the Streptococcus bovis Group: Classification, Identification, and Disease Associations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15825011" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Bacteremia due to Streptococcus gallolyticus, or the perils of revised nomenclature in bacteriology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18614655" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27117515" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Bacteremia with the bovis group streptococci: species identification and association with infective endocarditis and with gastrointestinal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4843895" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4843895" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9542954" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Bile-esculin test for presumptive identification of enterococci and streptococci: effects of bile concentration, inoculation technique, and incubation time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2915024" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10753212" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Promotion of intestinal carcinogenesis by Streptococcus bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27796646" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Streptococcus bovis new taxonomy: does subspecies distinction matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27720207" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283085" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : 16S ribosomal DNA sequence analysis distinguishes biotypes of Streptococcus bovis: Streptococcus bovis Biotype II/2 is a separate genospecies and the predominant clinical isolate in adult males.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17215341" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24797169" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18183440" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19273776" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15660254" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18955638" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26699595" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Streptococcus bovis endocarditis: Update from a multicenter registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21960713" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35730935" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Bacteraemia and infective endocarditis with Streptococcus bovis-Streptococcus equinus-complex: a retrospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12090865" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Changing profile of infective endocarditis: results of a 1-year survey in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15156477" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23558362" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Streptococcus bovis/Streptococcus equinus complex fecal carriage, colorectal carcinoma, and infective endocarditis: a new appraisal of a complex connection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17501973" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Characteristics and regional variations of group D streptococcal endocarditis in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25978355" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Potential Transmission Pathways of Streptococcus gallolyticus subsp. gallolyticus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25605355" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Streptococcus gallolyticus subsp. gallolyticus from human and animal origins: genetic diversity, antimicrobial susceptibility, and characterization of a vancomycin-resistant calf isolate carrying a vanA-Tn1546-like element.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8682035" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Infective endocarditis due to Streptococcus bovis. A report of 53 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2357141" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The triad of Streptococcus bovis bacteremia, colonic pathology, and liver disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11284936" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Definite streptococcus bovis endocarditis: characteristics in 20 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15902530" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20659498" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Streptococcus bovis bacteraemia revisited: clinical and microbiological correlates in a contemporary series of 59 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/408687" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Association of Streptococcus bovis with carcinoma of the colon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22563018" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23934596" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Is colonoscopy necessary in cases of infection by Streptococcus bovis biotype II?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21451000" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/484953" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Streptococcus bovis septicemia and carcinoma of the colon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9771449" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1823534" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Fecal carriage of Streptococcus bovis and colorectal adenomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19925668" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23831427" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14742316" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/666468" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Streptococcus bovis bacteremia and underlying gastrointestinal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3966453" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1494518" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Streptococcus bovis endocarditis as a presenting manifestation of idiopathic ulcerative colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15166750" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Non-life-threatening sepsis: report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7983908" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : [Staphylococcus bovis infective endocarditis associated with gastric adenocarcinoma].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11676950" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9875088" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26992635" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Streptococcus bovis septic arthritis and osteomyelitis: A report of 21 cases and a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8523020" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Streptococcus bovis-infected total hip arthroplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11812710" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Discitis associated with pregnancy and spinal anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22075594" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A longitudinal case series description of meningitis due to Streptococcus gallolyticus subsp. pasteurianus in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26879740" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Diagnosis and Treatment of Childhood Meningitis Caused by Streptococcus bovis Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25144798" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Childhood meningitis caused by Streptococcus bovis group: clinical and biologic data during a 12-year period in France.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8597340" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : [Neurologic complications of infectious endocarditis].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9356795" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Streptococcus bovis infection of the central nervous system: report of two cases and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26314916" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Streptococcus gallolyticus meningitis in adults: report of five cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26259921" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Streptococcus gallolyticus (bovis): a rare presentation of meningitis in the ED.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8161638" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11115925" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Streptococcus bovis bacteremia associated with Strongyloides stercoralis colitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20001733" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A cluster of bloodstream infections caused by Streptococcus gallolyticus subspecies pasteurianus that involved 5 preterm neonates in a university hospital during a 2-month period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27355933" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Streptococcus Gallolyticus Subsp. Pasteurianus Infection In A Neonatal Intensive Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32768337" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clustering of Streptococcus gallolyticus subspecies pasteurianus bacteremia and meningitis in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35815109" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Intrauterine infection and postpartum bacteremia due to Streptococcus gallolyticus subsp gallolyticus: An emerging concern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8648071" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Spontaneous peritonitis caused by Streptococcus bovis: search for colonic neoplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12827532" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Continuous ambulatory peritoneal dialysis-related peritonitis caused by Streptococcus bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10763992" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Spontaneous bacterial peritonitis caused by Streptococcus bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25416160" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Is Streptococcus bovis a urinary pathogen?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27084880" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Clinical interest of Streptococcus bovis isolates in urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26373316" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15722390" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21752968" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15793162" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Genetic basis of antibiotic resistance in clinical isolates of Streptococcus gallolyticus (Streptococcus bovis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15673778" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30678042" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : An Overview on Streptococcus bovis/Streptococcus equinus Complex Isolates: Identification to the Species/Subspecies Level and Antibiotic Resistance.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
